Mohammad Chaudhry, MD
Interventional Cardiology · Mechanicsville, VANPI 1598978850
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (40.4%), other and food and beverage — rather than concentrated in one kind of arrangement. 31 manufacturers reported payments, led by Angiodynamics, Inc. at 37.4% of the total. Reporting peaked in 2024 at $19,606 and has fallen 89.0% since, to $2,166 in 2025.
Across 206 payments — averaging $142.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$11K
- Medtronic$10K
- Abbott$3K
- Corindus Inc.$2K
- Edwards Lifesciences$660
- Boston Scientific$311
- plus $2K from 25 others
What the payments were for
- Travel & lodging$11,86340%
- Food & beverage$6,51322%
- Education$460%
- Other$10,91737%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 5 | $10,970 |
| Medtronic(2 entities) | 45 | $10,169 |
| Abbott | 34 | $3,291 |
| Corindus Inc. | 9 | $2,093 |
| Edwards Lifesciences | 27 | $660 |
| Boston Scientific | 5 | $311 |
| Novartis | 16 | $269 |
| Bard Peripheral Vascular, Inc. | 2 | $182 |
| Boehringer Ingelheim | 8 | $145 |
| Atricure, Inc. | 2 | $131 |
| Johnson & Johnson | 5 | $103 |
| Amgen | 6 | $103 |
| E.r. Squibb & Sons, L.L.C. | 7 | $95 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 6 | $93 |
| Pfizer | 5 | $93 |
| Cardiva Medical, Inc. | 4 | $82 |
| W. L. Gore & Associates, Inc. | 1 | $71 |
| Impulse Dynamics (USA) Inc. | 1 | $68 |
| Abiomed | 1 | $67 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $44 |
| Lexicon Pharmaceuticals, Inc. | 2 | $41 |
| Novo Nordisk | 2 | $40 |
| Scpharmaceuticals Inc. | 1 | $37 |
| Penumbra, Inc. | 2 | $33 |
| Philips North America LLC | 2 | $33 |
| Siemens Medical Solutions USA, Inc. | 1 | $27 |
| Heartflow, Inc. | 1 | $25 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Cook Medical LLC | 1 | $17 |
| Alnylam Pharmaceuticals Inc. | 1 | $15 |
| Gilead | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auryon Laser System 100-120 Vac$10,917
- CorPath GRX$1,881
- Omnilink Elite vascular stent system$1,560
- Abre$465
- MitraClip$366
- Mitra Clip system$358
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$175
- MitraClip System$165
- Venclose Maven Catheter$163
- Watchman$138
- Supera peripheral stent system$134
- SAPIEN 3 Ultra RESILIA$127
- COBALT DR MRI SURESCAN$126
- COREVALVE EVOLUT R$125
- TRICLIP$118
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$111
- SYMPLICITY G3$103
How this compares
$29,339 in reported general payments places this provider in the 85th percentile of 176 interventional cardiology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 103 | $121,111 |
| EntrestoSacubitril/Valsartan | 44 | $50,606 |
| Repatha SureclickEvolocumab | 57 | $46,065 |
| FarxigaDapagliflozin Propanediol | 17 | $24,417 |
| XareltoRivaroxaban | 28 | $24,103 |
| Praluent PenAlirocumab | 17 | $11,447 |
| Ranolazine ErRanolazine | 24 | $2,640 |
| Amiodarone Hcl | 17 | $1,291 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 43 | $987 |
| Bumetanide | 16 | $839 |
| Metoprolol Succinate | 80 | $716 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 69 | $709 |
| Ezetimibe | 52 | $649 |
| Carvedilol | 65 | $643 |
| Nebivolol Hcl | 16 | $613 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $93 | $121,111103 claims |
| NovartisEntresto | $269 | $50,60644 claims |
| Johnson & JohnsonXarelto | $103 | $24,10328 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 176 interventional cardiology providers in Virginia.
Other interventional cardiology in Mechanicsville
- Brian KaminskyMechanicsville$33K
- Deepak TalrejaVirginia Beach$1.5M
- Rajiv TayalFredericksburg$984K
- Gansevoort DunningtonRichmond$440K
- Matthew SummersNorfolk$308K
- Noah JonesFalls Church$238K
- Michael GenVirginia Beach$207K
- Jeremy BockLeesburg$202K
- Wayne BatchelorFalls Church$196K
- Matthew SherwoodFalls Church$193K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.